Your Anxiety Has a Cause. We Find It.
You've been told it's "just anxiety." Maybe therapy helped, maybe medication took the edge off, did nothing, or left you feeling like a flatter version of yourself. Maybe you were told your labs are normal and there's nothing left to check.
We don't guess which system is driving it. We test for it, we name it, and we build a staged clinical protocol around what we actually find in you.
"Anxiety is not one thing. Generalized, social, and panic presentations share the same biological substrate, but the dominant driver, and the right entry point, is different for each. That is why treating only the one driver a given pill or therapy happens to target is why so many people plateau."
.svg)
Anxiety Has Up To Seven Measurable Drivers
Before we talk about treatment, we look for which of these are active in you, because the right intervention depends entirely on the answer. Most patients over 30 with persistent anxiety are running dysfunction in more than one at once.
.png)
HPA-Axis Hyperactivation
Chronic stress keeps cortisol elevated, which suppresses BDNF, amplifies amygdala reactivity, and weakens the prefrontal cortex's control over it. A self-sustaining loop, not a personality trait.
.png)
GABA-A Receptor Deficit
The brain's primary braking system can downregulate through chronic stress, prior benzodiazepine use, or genetics, leaving a nervous system that struggles to turn itself off.
.png)
Amygdala Hyperreactivity & CRF Overexpression
The threat-detection center runs hot while the prefrontal "this isn't actually dangerous" signal loses its grip. The neurobiological basis of intrusive worry, social fear, and panic.
Autonomic Dysregulation & Low HRV
Sustained sympathetic activation with parasympathetic withdrawal is an objective, measurable state, not a feeling. Low heart-rate variability is a real biomarker, and it is trainable and treatable once identified.
.png)
Neuroinflammation
A specific cascade, not generic inflammation: NF-kB signaling drives IL-6 and TNF-alpha, activating the IDO enzyme and shunting tryptophan away from serotonin into neurotoxic kynurenine metabolites. The fog-and-dread quality many patients can't name.
BDNF Deficit & Impaired Fear Extinction
Cortisol, poor sleep, and neuroinflammation suppress BDNF, the growth factor your brain needs to consolidate new "this is safe" memories. Without it, exposure therapy has less biological substrate to work with.
Gut-Brain Axis Disruption
Vagal signaling, intestinal permeability, and the microbiome interact with the HPA axis and inflammatory tone. Anxiety can be maintained by a system most evaluations never examine.
Three Presentations, Three Entry Points
Generalized Anxiety
Typically chronic HPA hyperactivation plus GABAergic deficit: persistent worry, hypervigilance, and somatic tension. Entry point: HPA-axis normalization and GABA-A restoration together, with foundational substrate correction.
Social Anxiety
Driven by amygdala hyperactivation to social cues plus a breakdown in prefrontal safety signaling. Entry point: targeted neuropeptide therapy timed around structured exposure to amplify the extinction window.
Panic Disorder
Driven by brainstem CO2 hypersensitivity and autonomic dysregulation (low vagal tone, sympathetic dominance). Entry point: interventional autonomic-reset therapy first, addressing the mechanism, not just the attack in front of you.
How We Find Your Drivers
1
Structured driver-mapping intake
Maps symptom burden, phenotype, and biological driver pattern at once.
2
Paired brain measurement
Brain Gauge (eight domains against age-matched norms) and WAVi EEG (P300 amplitude and latency, peak alpha frequency, frontal asymmetry, theta/alpha ratio), always together, at intake and at defined checkpoints.
3
A real lab workup
HPA-axis cortisol curve, inflammatory markers (hs-CRP, homocysteine, and the tryptophan-to-kynurenine ratio where relevant), serum BDNF, and genetic markers relevant to methylation, dopamine tone, and treatment response.
4
HRV tracking
An ongoing, objective marker of autonomic recovery, tracked against your own baseline over time, not a single number in isolation.
.png)
The Modalities We Use
Every intervention is selected because it matches a specific, measured driver in you, not because it's on a menu. Formulation, dose, and sequencing are built individually from your evaluation.
A Staged Protocol, Not A Grab Bag
Substrate Correction
Foundational nutrient, gut-barrier, and inflammatory correction, informed by your labs. You can't build neuroplasticity work on an unaddressed deficiency.
Driver-Targeted Normalization
HPA-axis, GABAergic, and autonomic normalization, prioritized by your dominant driver, using the modalities matched to what your evaluation found.
Neuroplasticity & Extinction Priming
Once foundations are stable, BDNF-supportive and fear-extinction work are layered in, timed alongside therapeutic exposure where applicable.
F.A.Q.
Not automatically, and not by default. We coordinate with your existing care team where useful and with your permission, and we build around what actually helps you, which for many patients includes therapy and medication alongside driver-targeted treatment. We will never tell you to stop a prescribed medication abruptly.
Standard panels rarely include the specific markers that reveal an active neuroinflammatory, HPA-axis, or gut-brain driver. "Normal" on a standard panel and "no active biological driver" are not the same finding.
Yes. Brain Gauge and WAVi EEG, administered together, are a standard part of the evaluation and are repeated at defined checkpoints to confirm the plan is actually working, not just assumed to be.
A typical intake identifies a diagnosis and starts a medication trial. We map which of up to seven distinct biological drivers are active in you first, using objective brain measurement and targeted lab work, then build a staged protocol around what we actually find.
No. Peak Body and Mind is not an emergency service. If you're in immediate danger or having thoughts of harming yourself, call or text 988, call 911, or go to your nearest emergency department.
You'll complete the structured driver-mapping intake, undergo Brain Gauge and WAVi EEG in-office, and review your lab panel with your clinician. From there, we build your specific, staged plan together.
What This Is Not
Not a diagnosis-and-prescription model: we test for the drivers active in you before recommending anything.
Not a fixed menu: the modality, formulation, and sequence in your case are built from your labs, brain measurement, and presentation.
Not a replacement for the right medication or therapy: we coordinate with, not against, appropriate existing care.
Not a wellness trend: every modality answers a specific clinical question about a measured driver. If your evaluation doesn't support it, it isn't part of your plan.
Stop treating the label. Find the driver.
If you've been told it's "just anxiety," or that your labs are normal and there's nothing left to check, a driver-based evaluation may reveal what standard care missed. We test, we name it, and we build the plan around what we find in you.
This page is educational and is not a diagnosis or a substitute for individualized medical advice. If you are in crisis, call or text 988, call 911, or go to your nearest emergency department.
